In this article we're going to look into what penny stocks are and which are the 10 best penny stocks to buy now. Click to skip ahead and jump straight to the 5 best penny stocks to buy now.
If you've been around investing for even a short time, or if you've at least watched or read "Wolf of Wall Street", you have heard about the term "penny stocks". Penny stocks are categorized by the SEC as those that trade for less than $5 per share. Although it's not uncommon to classify as penny stocks those companies whose shares trade for under $1 and especially those that trade on the loosely-regulated Over-the-Counter market.
The main reason why people buy penny stocks is their cheap price, which allows buying a large amount of shares for a relatively small sum. The shares are bought in the hope that when the stock skyrockets, it will result in huge returns. So buying penny stocks provides investors the opportunity to be on the "ground zero" of a company. Or at least that's how they are presented.
Let's say company X is a biotech company working on a drug that could be a breakthrough in treating some disease. Now, this company opted for listing its stock to raise capital, instead of finding other sources. Its stock is trading at $0.50 per share. Let's assume the company is successful and it manages to develop the drug and it's approved by the regulators, so the stock price jumps to $5.00, which represents a 10-fold increase. If you'd invested $1,000 in the stock, you'd collect $10,000.
Best Penny Stocks To Buy Now
This sounds quite appealing, right? However, the reality is that most penny stocks never appreciate significantly, and out of those few that do grow, most of the gains are collected not by regular investors, but by penny-stock promoters and people launching pump-and-dump schemes. One rule of thumb is if you want to invest in penny stocks, don't do so by subscribing to various emails that promise you the next breakout trade that will give you 1,000% in return in 3 months.
So, while there are many other rules that can guide you about how to trade penny stocks, we would like to talk to you about how to pick them. More specifically, we would like to present you with a list of the 10 best penny stocks to buy now based on hedge fund sentiment, a metric that we believe is a good indicator of a stock's reliability. Hedge funds spend a lot of resources on researching their trades and when they're bullish on a penny stock, it means that it has potential for a solid growth over the long-run.
We are following hedge funds and identifying their most popular picks because we believe that this is a strategy that has the potential to beat the market. And we don't just believe it, but we have the research and historical evidence to back this up. Since March 2017, our diversified portfolio of monthly newsletter's stock picks (which are sourced from 13F filings, hedge fund presentations, and investor letters) returned 145%, beating the benchmark S&P 500 ETF (SPY) by more than 78 percentage points. Follow this link to find out more about our strategy and to download a free sample issue of our newsletter.
Without any further ado, let's take a look at 10 best penny stocks to buy now. To compile this list we identified the most popular stocks among the hedge funds we track at Insider Monkey, whose price is less than $5.00 per share. You can skip ahead and see which are the top 5 best penny stocks to buy now by clicking on this link.
Ambev ADR (NYSE:ABEV) saw a significant increase in the number of bullish investors - from 13 to 21 funds during the third quarter. Moreover, the aggregate value of their holdings surged to $790.35 million from $517.66 million. Among these funds, the top position is held by Jean-Marie Eveillard's First Eagle Investment Management, which owns 216.29 million shares worth $488.81 million. Other notable shareholders are Nicolai Tangen's Ako Capital and Jim Simons' Renaissance Technologies.
Broyhill Asset Management talked about ABEV in their 2020 Q2 investor letter. Here is what they said:
“We also diversified our beer exposure during the quarter, adding a direct investment in Ambev (ABEV) to compliment our existing investment in Anheuser Busch Inbev (BUD). As the current environment has punished highly leveraged businesses like BUD (despite the company’s ability to generate strong and recurring cash flow), the opportunity to own ABEV, with net cash on its balance sheet and the highest returns on capital in the industry—at a lower multiple than its parent—was too good to pass up.
ABEV is up more than 50% since May, however, we still think it still has an upside potential of more than 30% in the next 12 months. We actually considered adding ABEV to our monthly newsletter's recommendation list, however, we uncovered another deeply undervalued stocks that has an upside potential of 200% and we recommended that stock instead.
WETF ranks 9th in our list of the 10 best penny stocks to buy now. The number of funds betting on WisdomTree Investments Inc (NASDAQ:WETF) went up by four to 22 between July and September. Jim Simons' Renaissance Technologies disclosed holding $10.86 million shares worth of WisdomTree Investments in its latest 13F filing, followed by Daniel Johnson's Gillson Capital with a $4.92 million position.
WisdomTree Investments shares returned nearly 40% since the end of September and now trade near the high achieved back in February. Even though the stock offers a 2.5% dividend yield, we don't think it is a screaming buy at this price. It may still outperform the market in 2021 as income hungry investors will probably rush into dividend stocks after we defeat the coronavirus pandemic towards the end of the first half of the year.
NEX ranks 8th in our list of the best penny stocks to buy now. There were 22 funds holding shares of Nextier Oilfield Solutions Inc (NYSE:NEX) at the end of September, down by two over the quarter. Among the funds tracked by Insider Monkey, Stephen Feinberg's Cerberus Capital Management is the top shareholder of the company, reporting ownership of 40.08 million shares worth $71.93 million in its latest 13F filing.
We saw a bunch of insider sales in NEX shares in early 2019 when NEX was trading above $10. NEX closed 2019 at slightly below $7 and today trade at only $$3.52. This is a risky stock operating in a very risky industry. Even though there are a lot of hedge funds holding this micro-cap stocks, traditional conservative fund managers are staying away. We believe hedge funds have the better odds on their side as NEX doesn't carry a lot of debt on its balance sheet (it isn't like OXY or Exxon) and we are only a few months away from the end of the coronavirus pandemic. We have better stocks in our monthly newsletter's portfolio than NEX, but we don't think you'll regret if you dip your toes into Nextier Oilfield Solutions at $3.50.
DVAX ranks 7th in our list of the 10 best penny stocks to buy now. In Dynavax Technologies Corporation (NASDAQ:DVAX), there were 23 investors tracked by Insider Monkey holding positions, versus 17 funds a quarter earlier, although the total value of these positions dropped to $58.10 million from $122.51 million a quarter earlier. One of the investors that added Dynavax Technologies Corporation to its portfolio during the third quarter is Israel Englander's Millennium Management, which acquired 1.12 million shares.
Dynavax is a vaccine company, known for its hepatitis B vaccine. Unfortunately, it isn't selling a lot of this vaccine and still losing money. That's why earlier this year it ventured into COVID-19 vaccine business. According to Motley Fool "Dynavax is developing an adjuvant against the coronavirus called CpG 1018, which consists of short DNA molecules that mimic viral genetic material. These strands are added to conventional vaccines, boosting immune response while enhancing the vaccine's efficacy". Dynavax's shares popped above $12 in July due to vaccine optimism, but as you can guess gave back those gains. We don't like risking our hard saved dollars in speculative vaccine plays, especially now that Pfizer (PFE) has an FDA approved vaccine with 94% efficacy and another mRNA based vaccine is near approval. If Pfizer's vaccine had an efficacy of 60%, we might have felt like gambling a little bit. That's not the case, so even though hedge funds think this is a good stock to buy, we won't swing at this pitch.
BGC Partners, Inc. (NASDAQ:BGCP) saw the number of bullish investors dropping by five to 23 during the third quarter. The top shareholder of BGC Partners among the investors in our database is Amy Minella's Cardinal Capital, followed by David Rosen's Rubric Capital Management, which held stakes valued at $34.40 million and $22.65 million, respectively, at the end of September.
BGC Partners is down about 30% over the last 12 months, but its shares gained nearly 70% over the last two months. We don't think BGCP is done with its recovery. Hedge funds are betting on that as life starts to go back normal and economic growth picks up, BGCP will keep increasing and continue to deliver them outsized gains. Click to skip ahead and jump straight to the 5 best penny stocks to buy now. Suggested Articles:
